122 related articles for article (PubMed ID: 2428943)
1. Gilles de la Tourette's syndrome. A postmortem neuropathological and immunohistochemical study.
Haber SN; Kowall NW; Vonsattel JP; Bird ED; Richardson EP
J Neurol Sci; 1986 Sep; 75(2):225-41. PubMed ID: 2428943
[TBL] [Abstract][Full Text] [Related]
2. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain.
Haber SN; Watson SJ
Neuroscience; 1985 Apr; 14(4):1011-24. PubMed ID: 2582307
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease.
Marshall PE; Landis DM; Zalneraitis EL
Brain Res; 1983 Dec; 289(1-2):11-26. PubMed ID: 6198034
[TBL] [Abstract][Full Text] [Related]
4. Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry.
Haber SN; Nauta WJ
Neuroscience; 1983 Jun; 9(2):245-60. PubMed ID: 6192358
[TBL] [Abstract][Full Text] [Related]
5. Loss of substance P and enkephalin immunoreactivity in the human substantia nigra after striato-pallidal infarction.
Pioro EP; Hughes JT; Cuello AC
Brain Res; 1984 Feb; 292(2):339-47. PubMed ID: 6198046
[TBL] [Abstract][Full Text] [Related]
6. The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatopallidal and striatonigral projection neurons in birds and reptiles.
Reiner A
Brain Res; 1986 Apr; 371(1):155-61. PubMed ID: 2423185
[TBL] [Abstract][Full Text] [Related]
7. Elevated CSF dynorphin A [1-8] in Tourette's syndrome.
Leckman JF; Riddle MA; Berrettini WH; Anderson GM; Hardin M; Chappell P; Bissette G; Nemeroff CB; Goodman WK; Cohen DJ
Life Sci; 1988; 43(24):2015-23. PubMed ID: 2463450
[TBL] [Abstract][Full Text] [Related]
8. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
[TBL] [Abstract][Full Text] [Related]
9. The relationship between ventral striatal efferent fibers and the distribution of peptide-positive woolly fibers in the forebrain of the rhesus monkey.
Haber SN; Wolfe DP; Groenewegen HJ
Neuroscience; 1990; 39(2):323-38. PubMed ID: 1708114
[TBL] [Abstract][Full Text] [Related]
10. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans.
Reiner A; Medina L; Haber SN
Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817
[TBL] [Abstract][Full Text] [Related]
11. The distribution of substance P in the primate basal ganglia: an immunohistochemical study of baboon and human brain.
Beach TG; McGeer EG
Neuroscience; 1984 Sep; 13(1):29-52. PubMed ID: 6208509
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis.
Sapp E; Ge P; Aizawa H; Bird E; Penney J; Young AB; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Jan; 64(2):397-404. PubMed ID: 7535402
[TBL] [Abstract][Full Text] [Related]
13. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
[TBL] [Abstract][Full Text] [Related]
14. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions.
Marksteiner J; Saria A; Kirchmair R; Pycha R; Benesch H; Fischer-Colbrie R; Haring C; Maier H; Ransmayr G
Eur J Neurosci; 1993 Dec; 5(12):1573-85. PubMed ID: 7510203
[TBL] [Abstract][Full Text] [Related]
15. Histochemical visualization of neutral endopeptidase-24.11 (enkephalinase) activity in rat brain: cellular localization and codistribution with enkephalins in the globus pallidus.
Back SA; Gorenstein C
J Neurosci; 1989 Dec; 9(12):4439-55. PubMed ID: 2593007
[TBL] [Abstract][Full Text] [Related]
16. Histochemical identification of pallidal and striatal structures in the lizard Gekko gecko: evidence for compartmentalization.
Russchen FT; Smeets WJ; Hoogland PV
J Comp Neurol; 1987 Feb; 256(3):329-41. PubMed ID: 2437160
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of differential substance P-, met-enkephalin-, and glutamic-acid-decarboxylase-containing cell body and axon distributions in the corpus striatum of the cat.
Beckstead RM; Kersey KS
J Comp Neurol; 1985 Feb; 232(4):481-98. PubMed ID: 2579980
[TBL] [Abstract][Full Text] [Related]
18. Anatomical relationship between the basal ganglia and the basal nucleus of Meynert in human and monkey forebrain.
Haber S
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1408-12. PubMed ID: 3469674
[TBL] [Abstract][Full Text] [Related]
19. The comparison between enkephalin-like and dynorphin-like immunoreactivity in both monkey and human globus pallidus and substantia nigra.
Haber SN; Watson SJ
Life Sci; 1983; 33 Suppl 1():33-6. PubMed ID: 6141493
[TBL] [Abstract][Full Text] [Related]
20. Deep brain stimulation of anteromedial globus pallidus interna for severe Tourette's syndrome.
Cannon E; Silburn P; Coyne T; O'Maley K; Crawford JD; Sachdev PS
Am J Psychiatry; 2012 Aug; 169(8):860-6. PubMed ID: 22772329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
